GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (FRA:PQIA) » Definitions » Total Liabilities

RadNet (FRA:PQIA) Total Liabilities : €1,741 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is RadNet Total Liabilities?

RadNet's Total Liabilities for the quarter that ended in Mar. 2024 was €1,741 Mil.

RadNet's quarterly Total Liabilities declined from Sep. 2023 (€1,772.68 Mil) to Dec. 2023 (€1,721.31 Mil) but then increased from Dec. 2023 (€1,721.31 Mil) to Mar. 2024 (€1,740.85 Mil).

RadNet's annual Total Liabilities increased from Dec. 2021 (€1,515.40 Mil) to Dec. 2022 (€1,833.68 Mil) but then declined from Dec. 2022 (€1,833.68 Mil) to Dec. 2023 (€1,721.31 Mil).


RadNet Total Liabilities Historical Data

The historical data trend for RadNet's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet Total Liabilities Chart

RadNet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,272.46 1,256.31 1,515.40 1,833.68 1,721.31

RadNet Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,794.18 1,794.58 1,772.68 1,721.31 1,740.85

RadNet Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RadNet's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=401.143+(1299.54+6.1640000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+14.467+0)
=1,721

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=2467.164-745.85
=1,721

RadNet's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=393.656+(1329.207+4.668
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+13.321+0)
=1,741

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=2731.991-991.139
=1,741

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RadNet Total Liabilities Related Terms

Thank you for viewing the detailed overview of RadNet's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


RadNet (FRA:PQIA) Business Description

Traded in Other Exchanges
Address
1510 Cotner Avenue, Los Angeles, CA, USA, 90025
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

RadNet (FRA:PQIA) Headlines

No Headlines